Abstract:Human APOBEC3 enzymes are a family of single-stranded (ss)DNA and RNA cytidine deaminases that act as part of the intrinsic immunity against viruses and retroelements. These enzymes deaminate cytosine to form uracil which can functionally inactivate or cause degradation of viral or retroelement genomes. In addition, APOBEC3s have deamination independent antiviral activity through protein and nucleic acid interactions. If expression levels are misregulated, some APOBEC3 enzymes can access the human genome leading to deamination and mutagenesis, contributing to cancer initiation and evolution. While APOBEC3 enzymes are known to interact with large ribonucleoprotein complexes, the function and RNA dependence is not entirely understood. To further understand their cellular roles, we determined by affinity purification mass spectrometry (AP-MS) the protein interaction network for the human APOBEC3 enzymes and map a diverse set of protein-protein and protein-RNA mediated interactions. Our analysis identified novel RNA-mediated interactions between APOBEC3C, APOBEC3H Haplotype I and II, and APOBEC3G with spliceosome proteins, and APOBEC3G and APOBEC3H Haplotype I with proteins involved in tRNA methylation and ncRNA export from the nucleus. In addition, we identified RNA-independent protein-protein interactions with APOBEC3B, APOBEC3D, and APOBEC3F and the prefoldin family of protein folding chaperones. Interaction between prefoldin 5 (PFD5) and APOBEC3B disrupted the ability of PFD5 to induce degradation of the oncogene cMyc, implicating the APOBEC3B protein interaction network in cancer. Altogether, the results uncover novel functions and interactions of the APOBEC3 family and suggest they may have fundamental roles in cellular RNA biology, their protein-protein interactions are not redundant, and there are protein-protein interactions with tumor suppressors, suggesting a role in cancer biology.

APOBEC3s: DNA‐editing human cytidine deaminases

Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity

Molecular mechanism for regulating APOBEC3G DNA editing function by the non-catalytic domain

AID/APOBEC Deaminases Disfavor Modified Cytosines Implicated in DNA Demethylation

The APOBEC3 Family of Retroelement Restriction Factors

APOBEC3 proteins and genomic stability

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer

Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases

The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities

APOBEC3A damages the cellular genome during DNA replication

Crystal Structure of the C-terminal Deaminase Domain of APOBEC3G: Implications and Projections

Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function

Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA

The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences

Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer

Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates

APOBEC3A can activate the DNA damage response and cause cell‐cycle arrest

Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes

APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites

Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐amino‐1,2,4‐triazole‐3‐thiol Scaffold